{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-098817","form_type":"8-K","ticker":"TPST","cik":"0001544227","company_name":"Tempest Therapeutics, Inc.","filed_at":"2025-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.711486+00:00","generated_at":"2026-05-23T04:57:02.392250+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"confidence":"high","headline":"Tempest Therapeutics regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq notice on April 24, 2025 confirming compliance with Listing Rule 5550(a)(2).","Rule requires minimum bid price of $1.00 per share for continued listing.","Company had previously been notified of deficiency; now resolved.","No other regulatory or operational updates provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-098817","json":"https://secwatch.observer/filing/0001193125-25-098817.json","markdown":"https://secwatch.observer/filing/0001193125-25-098817.md","text":"https://secwatch.observer/filing/0001193125-25-098817.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1544227/000119312525098817/0001193125-25-098817-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1544227/000119312525098817/d935409d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T04:57:02.392250+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}